Annual Non Current Assets
$830.50 K
-$2.18 M-72.39%
31 December 2023
Summary:
Gain Therapeutics annual long term assets is currently $830.50 thousand, with the most recent change of -$2.18 million (-72.39%) on 31 December 2023. During the last 3 years, it has fallen by -$432.50 thousand (-34.24%). GANX annual non current assets is now -72.39% below its all-time high of $3.01 million, reached on 31 December 2022.GANX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$624.30 K
-$33.00 K-5.02%
30 September 2024
Summary:
Gain Therapeutics quarterly long term assets is currently $624.30 thousand, with the most recent change of -$33.00 thousand (-5.02%) on 30 September 2024. Over the past year, it has dropped by -$206.20 thousand (-24.83%). GANX quarterly non current assets is now -89.69% below its all-time high of $6.06 million, reached on 30 June 2022.GANX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GANX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -24.8% |
| 3 y3 years | -34.2% | -50.6% |
| 5 y5 years | +259.8% | - |
GANX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.4% | at low | -89.7% | at low |
| 5 y | 5 years | -72.4% | +259.8% | -89.7% | +1.3% |
| alltime | all time | -72.4% | +259.8% | -89.7% | +1.3% |
Gain Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $624.30 K(-5.0%) |
| June 2024 | - | $657.30 K(-8.0%) |
| Mar 2024 | - | $714.70 K(-13.9%) |
| Dec 2023 | $17.78 M(-15.7%) | $830.50 K(-3.0%) |
| Sept 2023 | - | $855.90 K(-10.1%) |
| June 2023 | - | $952.40 K(-52.4%) |
| Mar 2023 | - | $2.00 M(-33.5%) |
| Dec 2022 | $21.09 M | $3.01 M(-24.3%) |
| Sept 2022 | - | $3.98 M(-34.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $6.06 M(+402.0%) |
| Mar 2022 | - | $1.21 M(-4.5%) |
| Dec 2021 | $37.72 M(+319.7%) | - |
| Dec 2021 | - | $1.26 M(+25.3%) |
| Sept 2021 | - | $1.01 M(-1.0%) |
| June 2021 | - | $1.02 M(+54.9%) |
| Mar 2021 | - | $657.00 K(+6.6%) |
| Dec 2020 | $8.99 M(+1992.6%) | - |
| Dec 2020 | - | $616.50 K |
| Dec 2019 | $429.50 K | - |
FAQ
- What is Gain Therapeutics annual long term assets?
- What is the all time high annual non current assets for Gain Therapeutics?
- What is Gain Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Gain Therapeutics?
- What is Gain Therapeutics quarterly non current assets year-on-year change?
What is Gain Therapeutics annual long term assets?
The current annual non current assets of GANX is $830.50 K
What is the all time high annual non current assets for Gain Therapeutics?
Gain Therapeutics all-time high annual long term assets is $3.01 M
What is Gain Therapeutics quarterly long term assets?
The current quarterly non current assets of GANX is $624.30 K
What is the all time high quarterly non current assets for Gain Therapeutics?
Gain Therapeutics all-time high quarterly long term assets is $6.06 M
What is Gain Therapeutics quarterly non current assets year-on-year change?
Over the past year, GANX quarterly long term assets has changed by -$206.20 K (-24.83%)